6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole
98%
- Product Code: 195984
CAS:
953787-55-8
| Molecular Weight: | 415.369 g./mol | Molecular Formula: | C₁₆H₁₅F₂N₃O₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dryness, shading |
Product Description:
Used primarily as an intermediate in the synthesis of proton pump inhibitors (PPIs), this compound plays a key role in the development of medications that reduce gastric acid production. It is especially valuable in the preparation of anti-ulcer drugs, targeting conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Due to its sulfonyl and benzimidazole functional groups, it enables selective inhibition of the H+/K+-ATPase enzyme system in the parietal cells of the stomach, which is critical for acid secretion. Its difluoromethoxy and dimethoxy-oxidopyridinium moieties enhance metabolic stability and bioavailability in final drug formulations. Commonly used in pharmaceutical research and development, it supports the production of long-acting, potent acid-suppressive agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 20mg | 10-20 days | ฿2,808.00 |
+
-
|
| 50mg | 10-20 days | ฿3,888.00 |
+
-
|
| 100mg | 10-20 days | ฿5,670.00 |
+
-
|
| 250mg | 10-20 days | ฿9,450.00 |
+
-
|
| 1g | 10-20 days | ฿24,732.00 |
+
-
|
| bulk | 10-20 days | ฿0.00 |
+
-
|
6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole
Used primarily as an intermediate in the synthesis of proton pump inhibitors (PPIs), this compound plays a key role in the development of medications that reduce gastric acid production. It is especially valuable in the preparation of anti-ulcer drugs, targeting conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Due to its sulfonyl and benzimidazole functional groups, it enables selective inhibition of the H+/K+-ATPase enzyme system in the parietal cells of the stomach, which is critical for acid secretion. Its difluoromethoxy and dimethoxy-oxidopyridinium moieties enhance metabolic stability and bioavailability in final drug formulations. Commonly used in pharmaceutical research and development, it supports the production of long-acting, potent acid-suppressive agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :